European Journal of Endocrinology Impact Factor continues its steep rise!

The European Society of Endocrinology’s (ESE) Journal the European Journal of Endocrinology (EJE) has reached its highest ever Journal Impact FactorTM (JIF) in the 2020 Journal Citation ReportsTM (JCR) announced today (30 June, 2021). It confirms a steady trend over the past years, making it a rising star and global leader in publishing clinical and translational endocrinology research. The highly respected Journal achieved an Impact Factor of 6.664, placing it as number 20 out of 145 in the list of Endocrinology and Metabolism research journals in terms of Impact Factor. This underpins the leading role of ESE in fostering exchange and scientific discourse and promoting endocrinology.

 

Since 2012, the JIF of the European Journal of Endocrinology has grown consistently from a JIF of 3.791 to the new peak of 6.664 announced today, a true milestone now achieved 27 years after the creation of EJE. This consistent growth is the result of the dedication and hard work of the past Editors-in-Chief and Editorial Board members and the high-quality contributions by EJE’s authors, along with the global effort of field-leading reviewers in assessing the submissions.

 

Editor-in-Chief, Professor Wiebke Arlt, commented: “I am delighted to see EJE, the flagship journal of the European Society of Endocrinology, taking the global lead in publishing clinical and translational endocrinology and metabolism research. As an Editor-in-Chief, I am standing on the shoulders of giants who served before me, the founding editor Albert Burger, Paolo Beck-Peccoz (under whom I served as junior editor), Christian Strasburger and my predecessor Hans Romijn (under whom I served as Associate Editor and Reviews Editor).”

 

Professor Arlt continued: “I would like to thank my Deputy Editors Juliane Leger, Olaf Dekkers and Rob Semple for their outstanding work and the members of EJE’s fantastic global editorial board, featuring Associate Editors at the top of their game from 24 countries all around the globe. EJE’s success is based on their dedicated commitment and specialist expertise. Importantly, we could only achieve this due to the fantastic authors from all over the world who have sent us their best work in clinical and translational endocrinology. Special mention goes to our hard-working expert reviewers, who have helped EJE to maintain the highest standards of quality even during the demanding times of the pandemic”

 

ESE’s President, Professor Martin Reincke said: “The 2020 Journal Impact Factors are a milestone for the Society – we are all immensely proud of our Journals and thank the previous and current Editor- in-Chief and the editorial boards for their dedication and hard work. The foundation built over the years has enabled EJE to reach this new high. As the leading endocrine journal, EJE underpins ESE’s role as the voice for endocrinology in Europe and our mission of advancing endocrinology – improving science, knowledge and health across Europe, and ultimately benefiting patient care. Endocrine Connections also continues to gain valuable traction as a key journal for endocrine research dissemination.”

 

He continued: “The ongoing work of Professor Arlt and her Editorial Board will, I am sure, continue the success of EJE in attracting the best endocrine science from across the world and disseminating it to further the knowledge and practice of all those involved in treating patients with endocrine conditions.”

 

EJE publishes high-quality original clinical and translational research papers and reviews in adult and paediatric clinical and translational endocrinology, as well as clinical practice guidelines and position statements. Additionally, the consideration of endocrinology in a wide range of health areas (including obesity, cancer and diabetes) as well as rare endocrine diseases and also in the environment (endocrine disrupting chemicals – EDCs) has increased citations of EJE papers across many disciplines.

 

Endocrine Connections also increased its JIF from 2.592 to 3.335. Endocrine Connections publishes original research and reviews in all areas of endocrinology, with a focus on papers that have relevance to its related and intersecting disciplines and the wider biomedical community. The journal considers basic, translational and clinical studies. The recently appointed Editor-in-Chief is Professor Adrian Clark, who succeeded the founding editor of Endocrine Connections, Professor Josef Köhrle.

 

 

ENDS

 

Contact the Media Office

The media office can be contacted between 9am-5pm CET, Monday to Friday.

We can provide comment and expertise on all hormone-related issues. 

If you are a journalist and require help with a story or would like to receive European Society of Endocrinology press releases, please contact us on:

Telephone: 32 (0) 2 73 79 545
Email: ese-media@hkstrategies.com

Notes for Editors:

About Impact Factors, Web of Science (and Clarivate)

The Journal Impact FactorTM (JIF), often referred to as the Impact Factor (IF) of an academic journal is a scientometric index calculated by Clarivate that reflects the yearly average number of citations in a year to articles published in the previous two years in a given journal. It is frequently used as a proxy for the relative importance of a journal within its field; journals with higher Impact Factor values are often deemed to be more important, or carry more intrinsic prestige in their respective fields, than those with lower values. https://clarivate.com/webofsciencegroup/solutions/web-of-science/

 

About the European Journal of Endocrinology (EJE)

European Journal of Endocrinology publishes high-quality original clinical and translational research papers and reviews in paediatric and adult endocrinology, as well as clinical practice guidelines and position statements. EJE is published on behalf of the European Society of Endocrinology by Bioscientifica (since 1999) https://eje.bioscientifica.com/

 

The current Editor-in-Chief is Wiebke Arlt MD, DSc, FRCP, FMedSci, William Withering Chair of Medicine, Director of the Institute of Metabolism and Systems Research (IMSR), University of Birmingham, UK. Her research focus is on the role of steroid metabolism in human health and disease, with translational focus on androgen excess and adrenal disease

 

Established in 1994, EJE originally had a broad scope covering both basic and clinical endocrine research, however in 2008 the decision was made to focus on clinical and translational science, complementing the Society’s other journal, Endocrine Connections, an interdisciplinary fully open access journal (which ESE jointly owns with the Society for Endocrinology, UK) and the Society’s other official journals: Journal of Endocrinology (JIF 4.286), Journal of Molecular Endocrinology (JIF 5.098) and Endocrine-Related Cancer (JIF 5.678). ESE Members have free online access to all five of these official ESE journals. 

 

About the European Society of Endocrinology

The European Society of Endocrinology (ESE) provides a platform to develop and share leading research and best knowledge in endocrine science and medicine. By uniting and representing every part of the endocrine community, we are best placed to improve the lives of patients. Through the 54 National Societies involved with the ESE Council of Affiliated Societies (ECAS) ESE represents a community of over 20,000 European endocrinologists. We inform policy makers on health decisions at the highest level through advocacy efforts across Europe.

 

To find out more please visit www.ese-hormones.org.

Follow us on Twitter @ESEndocrinology,

Facebook @EuropeanSocietyofEndocrinology

and LinkedIn: linkedin.com/company/european-society-of-endocrinology.